Sp39

PANEL DISCUSSION

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence. This session will focus on what defines the epigenome, technologies that allow us to track the epigenome and how novel cancer therapies are developed that target regulators of the epigenome.

Tracks

Related Products

Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for THE EPIGENOME OF METAPLASIA
THE EPIGENOME OF METAPLASIA
The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence…
Thumbnail for ESOPREDICT: A CLINICALLY APPLICABLE PROGNOSTIC ASSAY FOR RISK STRATIFICATION OF PATIENTS WITH BARRETT’S ESOPHAGUS
ESOPREDICT: A CLINICALLY APPLICABLE PROGNOSTIC ASSAY FOR RISK STRATIFICATION OF PATIENTS WITH BARRETT’S ESOPHAGUS
Barrett’s esophagus (BE), a pre-malignant precursor of esophageal adenocarcinoma (EAC), when recognized early through screening, could potentially allow for endoscopic surveillance or endoscopic eradication therapy…